OnDosis Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5.56M
- Investors
-
9
OnDosis General Information
Description
Developer of a personalized medicine device intended to improve how patients manage and take medications. The company offers a dosage manager supporting flexible delivery of pellets, granules, mini tablets, and powders with integrated digital technologies and IoT connectivity, enabling patients and healthcare providers to achieve precise dosing and enhanced treatment management.
Contact Information
Website
www.ondosis.comCorporate Office
- Gemenskapens gata 9
- Pepparedsleden 1
- 431 53 Molndal
- Sweden
Corporate Office
- Gemenskapens gata 9
- Pepparedsleden 1
- 431 53 Molndal
- Sweden
OnDosis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 11-Jul-2025 | $5.56M | Completed | Product Development | ||
| 4. Later Stage VC (Series C) | 04-May-2022 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 24-May-2021 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 11-Sep-2020 | $3.44M | $8.09M | Completed | Startup | |
| 1. Seed Round | 01-Jan-2019 | $4.65M | $4.65M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
OnDosis Patents
OnDosis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202410048-D0 | Cloud computing and medicament dispenser | Inactive | 10-Jul-2024 | ||
| WO-2026013222-A1 | Cloud computing and medicament dispenser | Pending | 10-Jul-2024 | ||
| EP-4743046-A1 | Delivery device for medicament | Pending | 13-Jul-2023 | ||
| GB-202310788-D0 | Delivery device for medicament | Inactive | 13-Jul-2023 | ||
| WO-2025012463-A1 | Delivery device for medicament | Inactive | 13-Jul-2023 | A61J1/03 |
OnDosis Signals
OnDosis Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alsteron | Family Office | Minority | ||
| Rydgruppen | Venture Capital | Minority | ||
| Aeternum Capital (UK) | Asset Manager | Minority | ||
| Albonja | Venture Capital | Minority | ||
| Boston Consulting Group | Corporation | Minority |
OnDosis FAQs
-
When was OnDosis founded?
OnDosis was founded in 2017.
-
Where is OnDosis headquartered?
OnDosis is headquartered in Molndal, Sweden.
-
What is the size of OnDosis?
OnDosis has 20 total employees.
-
What industry is OnDosis in?
OnDosis’s primary industry is Biotechnology.
-
Is OnDosis a private or public company?
OnDosis is a Private company.
-
What is OnDosis’s current revenue?
The current revenue for OnDosis is .
-
How much funding has OnDosis raised over time?
OnDosis has raised $32.4M.
-
Who are OnDosis’s investors?
Alsteron, Rydgruppen, Aeternum Capital (UK), Albonja, and Boston Consulting Group are 5 of 9 investors who have invested in OnDosis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process